Literature DB >> 29460436

Truncating variants of the DLG4 gene are responsible for intellectual disability with marfanoid features.

S Moutton1,2, A-L Bruel2, M Assoum2, M Chevarin2, E Sarrazin3, C Goizet4, A-M Guerrot5, A Charollais6, P Charles7, D Heron7, A Faudet7, N Houcinat1,2, A Vitobello2, F Tran-Mau-Them1,2, C Philippe1,2, Y Duffourd2, C Thauvin-Robinet1,2, L Faivre1,2.   

Abstract

Marfanoid habitus (MH) combined with intellectual disability (ID) is a genetically and clinically heterogeneous group of overlapping disorders. We performed exome sequencing in 33 trios and 31 single probands to identify novel genes specific to MH-ID. After the search for variants in known disease-causing genes and non-disease-causing genes with classical approaches, we searched for variants in non-disease-causing genes whose pLI was above 0.9 (ExAC Consortium data), in which truncating variants were found in at least 3 unrelated patients. Only DLG4 gene met these criteria. Data from the literature and various databases also indicated its implication in ID. DLG4 encodes post-synaptic density protein 95 (PSD-95), a protein expressed in various tissues, including the brain. In neurons, PSD-95 is located at the post-synaptic density, and is associated with glutamatergic receptor signaling (NMDA and AMPA). PSD-95 probably participates in dendritogenesis. Two patients were heterozygous for de novo frameshift variants and one patient carried a a consensus splice site variant. Gene expression studies supported their pathogenicity through haploinsufficiency and loss-of-function. Patients exhibited mild-to-moderate ID, similar marfanoid features, including a long face, high-arched palate, long and thin fingers, pectus excavatum, scoliosis and ophthalmological manifestations (nystagmus or strabismus). Our study emphasizes the role of DLG4 as a novel post-synaptic-associated gene involved in syndromic ID associated with MH.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  DLG4; PSD-95; intellectual disability; marfanoid; synaptopathy; whole exome sequencing

Mesh:

Substances:

Year:  2018        PMID: 29460436     DOI: 10.1111/cge.13243

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners.

Authors:  Amanda M Levy; Paulino Gomez-Puertas; Zeynep Tümer
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

2.  A Novel miRNA-mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma.

Authors:  Xin Shang; Lan-Er Shi; Dina Taule; Zhang-Zhi Zhu
Journal:  Cancer Manag Res       Date:  2021-08-03       Impact factor: 3.989

Review 3.  Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders.

Authors:  Katelyn Cuttler; Maryam Hassan; Jonathan Carr; Ruben Cloete; Soraya Bardien
Journal:  Open Biol       Date:  2021-10-06       Impact factor: 6.411

4.  Investigation of Chromosomal Structural Abnormalities in Patients With Undiagnosed Neurodevelopmental Disorders.

Authors:  Ye Cao; Ho Ming Luk; Yanyan Zhang; Matthew Hoi Kin Chau; Shuwen Xue; Shirley S W Cheng; Albert Martin Li; Josephine S C Chong; Tak Yeung Leung; Zirui Dong; Kwong Wai Choy; Ivan Fai Man Lo
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

5.  Characterization of gene expression profiles in the mouse brain after 35 days of spaceflight mission.

Authors:  Jacob M Holley; Seta Stanbouly; Michael J Pecaut; Jeffrey S Willey; Michael Delp; Xiao Wen Mao
Journal:  NPJ Microgravity       Date:  2022-08-10       Impact factor: 4.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.